27.07.2014 Views

HAPPY AUDIT, L. Bjerrum, March 9 - Grace

HAPPY AUDIT, L. Bjerrum, March 9 - Grace

HAPPY AUDIT, L. Bjerrum, March 9 - Grace

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Health<br />

Alliance for Prudent<br />

Prescribing,<br />

Yield<br />

se of anti-microbial<br />

Drugs<br />

In n the Treatment<br />

of Respiratory Tract Infections<br />

And<br />

Use<br />

Proposal for EU DG Research, <strong>March</strong> 2006<br />

Coordinator: Research Unit of General Practice, Odense, Denmark


Research Unit for General Practice<br />

University of Southern Denmark


<strong>HAPPY</strong> <strong>AUDIT</strong><br />

Objective<br />

to reduce the occurrence of bacterial<br />

resistance<br />

by reducing prescribing of unnecessary<br />

antibiotics for respiratory tract infections<br />

by improving the use of appropriate<br />

antibiotics in suspected bacterial<br />

infections<br />

by Improving the quality of diagnostic<br />

procedures for RTIs in general practice


El PAIS, 2001


Correlation between penicillin use and prevalence of resistancy<br />

Gossens et al: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.<br />

The Lancet 2005


Participation of 450 GPs<br />

12<br />

from 12 regions<br />

Country<br />

Local<br />

No of<br />

Region<br />

partner<br />

GPs<br />

Denmark APOR<br />

1 Funen 100<br />

Sweden BIRD<br />

2 Blekinge 50<br />

Lithuania FDC<br />

3 Klaipeda 30<br />

Russia AFMK<br />

4 Kaliningrad 30<br />

France CPMF<br />

5 Paris 30<br />

Spain SEMFYC<br />

6 Madrid 30<br />

7 Catalonia 30<br />

8 Valencia 30<br />

9 Andalusia 30<br />

10 Galicia 30<br />

11 Gran Canaria 30<br />

Argentina 12 Missiones 30<br />

Total 450<br />

10<br />

9<br />

6<br />

5<br />

8<br />

7<br />

1<br />

2<br />

4<br />

3<br />

11


Facts:<br />

Antibiotic treatment in general practice<br />

GPs are responsible for >90% of all prescriptions<br />

of antibiotics in most countries<br />

The majority of prescriptions are for patients with<br />

respiratory tract infections<br />

Most respiratory tract infections are caused<br />

by virus<br />

Most respiratory infections are not dangerous<br />

Very few respiratory infections are serious or<br />

life threatening<br />

Only few respiratory infections need acute<br />

treatment<br />

Most prescriptions are issued for fear of<br />

serious infections – “just for sake”<br />

Overuse of antibiotics may lead to increased<br />

number of resistant bacteria


Distribution of focus for<br />

infections in General Practice<br />

Eyes<br />

11%<br />

Gyn<br />

5%<br />

GI<br />

1%<br />

Skin<br />

12%<br />

Urine<br />

12%<br />

Respiratory Tract<br />

60%<br />

Bronchii<br />

11%<br />

Lungs<br />

7%<br />

Ears<br />

8%<br />

Sinuses<br />

12%<br />

Tonsils<br />

17%<br />

Other<br />

4%


Some characteristics of Primary health<br />

care in participating countries<br />

Time allocated for a consultation<br />

Nordic countries: 10-15 15 minutes<br />

Spain 5-65<br />

6 minutes<br />

Diagnostic test in patients with<br />

respiratory tract infections<br />

<br />

<br />

Nordic countries: StrepA, CRP<br />

Spain, France: No tests<br />

Antibiotic treatment<br />

<br />

<br />

Nordic countries<br />

Narrow spectrum penicillin<br />

represents >50% of all<br />

prescriptions<br />

Spain, France<br />

Narrow spectrum penicillin are<br />

hardly not used


Different practice organization in<br />

Practice organization<br />

Denmark<br />

participating countries<br />

GPs are independent<br />

professionals working on a<br />

contractual base with the<br />

government (county)<br />

GPs are owners of practice<br />

Group practices of 2-42<br />

4 GPs<br />

Solo practices<br />

Spain<br />

GPs are employed by the NHS<br />

Health centres with 20-30 GPs<br />

per centre


Different pattern of contact to<br />

Denmark, Sweden:<br />

<br />

General Practice<br />

The GP represents the point of<br />

first encounter for >95% of<br />

people suffering health problems<br />

Spain, France<br />

<br />

Patients can contact other<br />

specialist directly<br />

Denmark, Sweden<br />

<br />

GPs are responsible for >90% of<br />

all prescriptions issued<br />

Spain, France<br />

<br />

GPs are responsible for the<br />

majority of prescriptions, but<br />

patients may also get antibiotics<br />

from:<br />

“Under the counter”<br />

prescriptions<br />

Other specialists


Audit Project<br />

Odense (APO)<br />

Organised as a quality development program within<br />

the Research Unit of General Practice, University of<br />

Southern Denmark<br />

Financed by research grants combined with fees for<br />

services<br />

Has activities in all Danish counties and all Nordic<br />

countries, incl. Greenland and The Faroe Islands<br />

Aims to combine well-known postgraduate training<br />

methods with a view to effectively implementing<br />

guidelines and new knowledge in general practice<br />

It is based on simple prospective self-registration<br />

It is voluntary


The APO method: A simple and practical method for quality<br />

development in primary care


Number of consultations today:<br />

Registration date:<br />

1<br />

2<br />

3<br />

4<br />

5<br />

6<br />

7<br />

8<br />

9<br />

10<br />

11<br />

12<br />

13<br />

14<br />

15<br />

sex<br />

day month year<br />

%<br />

Infection focus<br />

only 1 x<br />

1 - 3 x<br />

3 4 5 6 7 8 9 10 11 12 13 16<br />

only 1 x<br />

only 1 x<br />

min. 1 max. 7 x<br />

30<br />

only 1 x<br />

Remarks<br />

Copyright: Audit Projekt Odense, Winsløwparken 19 - 5000 Odense C, DK<br />

Number of consultations today:<br />

Registration date:<br />

1<br />

2<br />

3<br />

4<br />

5<br />

6<br />

7<br />

8<br />

9<br />

10<br />

11<br />

12<br />

13<br />

14<br />

15<br />

day<br />

sex<br />

month year<br />

%<br />

Type of<br />

contact Infection focus<br />

form<br />

only 1 x only 1 x only 1 x<br />

1 - 3 x<br />

3 4 5 6 7 8 9 10 11 12 13 16<br />

only 1 x<br />

only 1 x<br />

min. 1 max. 7 x<br />

30<br />

Certificate<br />

(sick-leave)<br />

only 1 x<br />

Remarks<br />

Copyright: Audit Projekt Odense, Winsløwparken 19 - 5000 Odense C, DK<br />

% af regi streringer<br />

100%<br />

75%<br />

50%<br />

25%<br />

0%<br />

Nor mal t<br />

O TOS KO PIFUN D<br />

Pat ologi sk<br />

norm al undertry k flad kurve andet ubrugel ig<br />

The Audit circle:<br />

GP:<br />

0 1<br />

<strong>AUDIT</strong>: Respiratory Infections in General Practice - 2001<br />

Contact<br />

Diagnosis and<br />

treatment<br />

Infection Antibiotic<br />

origin treatment<br />

Choice of antibiotics<br />

Date of Birth<br />

Total<br />

␇ 1 2 3 4 5 11 14 15 17 18 19 20 21 22 23 24 25 26 27 28 29 31 32 33<br />

First pilot<br />

First registration<br />

TYMPANOMETRIFUND RELATERET TIL OTOSKOPI FUND<br />

Project group<br />

First follow-up meeting<br />

Idea<br />

Analysis of<br />

quality problems<br />

Implementation strategy<br />

Final courses<br />

and evaluation<br />

GP:<br />

0 1<br />

Date of Birth<br />

Total<br />

<strong>AUDIT</strong>: Respiratory Infections in General Practice - 2001<br />

Con-<br />

only 1 x only 1 x<br />

Type of<br />

contact tact<br />

form<br />

Diagnosis and Infection<br />

treatment origin<br />

Antibiotic<br />

treatment<br />

Choice of antibiotics<br />

␇ 1 2 3 4 5 11 14 15 17 18 19 20 21 22 23 24 25 26 27 28 29 31 32 33<br />

Certificate<br />

(sick-leave)<br />

Courses<br />

Reminders<br />

Workshops<br />

Second registration


Guidelines - respiratory<br />

tract infections<br />

1995<br />

1997<br />

1999<br />

2002<br />

2004<br />

2006<br />

1992-93<br />

FIRST<br />

REGISTRATION<br />

Editorial<br />

board<br />

FINAL CONFERENCE<br />

CONSENSUS CONFERENCE<br />

SECOND<br />

REGISTRATION<br />

NEWSLETTER<br />

STRATEGY<br />

CONFERENCE<br />

NEWSLETTERv<br />

NEWSLETTERS


Change in treatment of pneumonia in<br />

Denmark 1992-1995<br />

70<br />

PERCENT<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

PENI-<br />

CILLIN<br />

AMPI-<br />

CILLIN<br />

ERYTHRO-<br />

MYCIN<br />

TETRA-<br />

CYCLINE<br />

OTHER<br />

ANTIB.<br />

OTHER<br />

MED.<br />

NO<br />

MED.<br />

24 G.P.'s<br />

1992 n=62 1993 n=127 1995 n=107


Antibiotic Audit 2001: variation between GPs<br />

Antibiotic prescription for tonsillitis in different practices in i<br />

Denmark before intervention<br />

Practices (%)<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

Consultations (%)<br />

90-100%<br />

80-89%<br />

70-79%<br />

60-69%<br />

50-59%<br />

40-49%<br />

30-39%<br />

20-29%<br />

10-19%<br />

0-9%


Antibiotic Audit 2002: variation between GPs<br />

Antibiotic prescription for tonsillitis in different practices in i<br />

Denmark after intervention<br />

Practices (%)<br />

40<br />

35<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

Consultations (%)<br />

90-100%<br />

80-89%<br />

70-79%<br />

60-69%<br />

50-59%<br />

40-49%<br />

30-39%<br />

20-29%<br />

10-19%<br />

0-9%


European Audit 2001<br />

Treatment of tonsillitis in different countries<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

Denmark Norway Sweden Spain<br />

Cephalosporine<br />

Macrolide<br />

Amoxacillin<br />

V-penicillin


European Audit 2001<br />

Use of tests in patients with tonsillitis in different countries<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

Denmark Norway Sweden Spain<br />

No test<br />

Other<br />

CRP<br />

StrepA


Percentage of consultations with antibiotic prescribing in relation to<br />

focus for infection<br />

%<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

Before intervention<br />

After Intervention<br />

20<br />

10<br />

0<br />

Ears<br />

Tonsils<br />

Pharynx<br />

Sinuses<br />

Bronchii/lungs<br />

Multiple foci<br />

Unknown focus<br />

All resp infections<br />

Focus for respiratory infection


Main results<br />

Effects of change<br />

The intervention led to a significant reduction in antibiotic<br />

prescribing.<br />

Before the intervention 36% (29%-44%) of consultations were<br />

followed by antibiotic prescribing<br />

After the intervention 24% (20%-29%) 29%) of consultations were<br />

followed by antibiotic prescribing<br />

The reduction was most pronounced in patients with sinusitis<br />

and lower RTIs.<br />

Lessons learnt<br />

Improvement of diagnostic procedures may lead to a<br />

reduction of antibiotic prescribing in primary health care<br />

in Spain.


How do we influence doctors to change<br />

their prescribing habbits ?<br />

Written material<br />

Training courses<br />

Prescription feedback<br />

Reminders<br />

Academic detailing<br />

Audit interventions<br />

Guidelines combined<br />

with other initiatives<br />

Etc…


How can doctors change habbits<br />

concerning antibiotic use?<br />

Important conditions for change<br />

of habbits<br />

Recognize that there is a<br />

problem, and something has<br />

to be changed<br />

Motivation and willingness to<br />

change habbits<br />

Feeling of a personal<br />

responsiblility for<br />

participating in the<br />

intervention


Experience from audit<br />

When performing guidelines<br />

for general practice they<br />

should be adapted to local<br />

conditions<br />

Initiatives should be taken to<br />

implement them in the most<br />

effective way, adapted to<br />

local conditions<br />

When introducing guidelines<br />

they should be followed up<br />

by other initiatives


What do patients with respiratory<br />

infections want from the GP ?<br />

Some patients with RTI expect the doctor to perform a test<br />

to confirm that they don’t t need antibiotics<br />

Frequent in Nordic countries<br />

Infrequent in Southern Europe<br />

Some patients with RTI expect the doctor to issue an<br />

antibiotic prescription for their symptoms<br />

Doctors are highly influenced by patients demand<br />

Prescribing may be a way of showing the patient<br />

that the doctor understands and accepts the<br />

patient’s s problem and is willing to help.


Why are antibiotics prescribed for non-<br />

bacterial infections ?<br />

Doctors may be too busy to perform a<br />

thorough examination or a laboratory<br />

investigation<br />

In a busy practice, a prescription can be used<br />

to terminate the consultation<br />

If you are in doubt you may prescribe ”just to<br />

be safe”


The consortium<br />

Participant organisation name<br />

Short name<br />

Type<br />

Research<br />

Country<br />

Internat.<br />

Health<br />

authority<br />

Assoc.<br />

of GPs<br />

SME<br />

Research Unit for General Practice in Odense RUPO DK GOV X<br />

GP Consultants GPC DK PRC X<br />

Ministry of the Interior and Health MIH DK GOV X<br />

Blekinge Institute for Research and Development BIRD SE PNP X<br />

National Board of Health and Welfare NBHW SE GOV X<br />

FD Centre FDC LT PNP X<br />

State Patient Fund SPF LT GOV X<br />

Association of Family Doctors, Kaliningrad AFMK RU PNP X<br />

College of Family Physicians in Paris CPMF FR PNP X<br />

Spanish Society of Family Medicine SEMFYC ES PNP X<br />

University of Las Palmas de Gran Canaria ULPGC ES GOV X<br />

Consejería de Sanidad del Gobierno de Canarias CSGC ES GOV X<br />

Misiones Association of General Family Medicine and<br />

Health Team<br />

AMMeGeFES AR PNP X<br />

World Health Organisation, Collaborating Centre for<br />

Drug Statistics Methodology<br />

WHO-CC NO INO X X<br />

World Organisation of Family Doctors WONCA SI INO X X X<br />

European Drug Utilisation Research Group EuroDURG BE INO X X<br />

17 participants from 8 EU countries and 2 INCO countries


Project structure<br />

Planning of audits and intervention<br />

WP2<br />

Planning of<br />

Audit<br />

cycles<br />

WP3<br />

Development<br />

of<br />

Indicators<br />

WP4<br />

Intervention<br />

material<br />

for Patients<br />

WP5<br />

Intervention<br />

for<br />

Professionals<br />

Audit<br />

implementation<br />

plan<br />

Audit<br />

guideline<br />

Intervention<br />

material for<br />

patients<br />

Intervention<br />

material for<br />

professionals<br />

Initial registration<br />

Intervention<br />

WP6 APO cycles in the Nordic Region (2 APO cycles)<br />

WP7 APO cycles in the Baltic Region (2 APO cycles)<br />

Final registration<br />

GP<br />

registration<br />

data<br />

WP10 Analysis<br />

of the audit<br />

results<br />

WP8 APO cycles in France (1 APO cycle)<br />

WP9 APO cycles in Hispano-America (7 APO cycles)<br />

Understanding the<br />

effect of intervention<br />

Analysis and dissemination<br />

WP11<br />

Evaluation and<br />

working<br />

conference<br />

Conclusions and<br />

recommendations<br />

GP<br />

registration<br />

data<br />

WP12<br />

Preparing<br />

material for<br />

media<br />

campaigns


Project time schedule<br />

2007 2008 2009 2010<br />

X<br />

X<br />

Analysis and conference<br />

Second registration of Patients<br />

Intervention: GPs and patients<br />

First registration of Patients<br />

First invitation of GPs<br />

Total project period: 3 years (April 2007 – <strong>March</strong> 2010)


Dissemination<br />

Follow-up meetings for GPs in each region<br />

<strong>HAPPY</strong> <strong>AUDIT</strong> Conference (month 36)<br />

Scientific publications and conference presentations<br />

Media campaigns targeting professionals and the<br />

public (to be financed by EU in separate projects)<br />

<strong>HAPPY</strong> <strong>AUDIT</strong><br />

<strong>HAPPY</strong> <strong>AUDIT</strong><br />

<strong>HAPPY</strong><br />

<strong>AUDIT</strong>


Time schedule<br />

First partner meeting: October 2005<br />

Submission to EU: <strong>March</strong> 2006<br />

Evaluation by EU: July 2006<br />

Contract negotiation: November 2006<br />

Project start: April 2007<br />

First registration: January 2008 *<br />

Second registration: January 2009 *<br />

End of project: <strong>March</strong> 2010<br />

* Plus 6 months for Argentina


Project time schedule<br />

Work package<br />

WP1 Project Management<br />

WP2 Planning of audit cycles<br />

WP3 Development of indicators<br />

WP4 Intervention materials for Patients<br />

WP5 Intervention materials for Professionals<br />

WP6 APO cycles in the Nordic Region (2 APO cycles)<br />

WP7 APO cycles in the Baltic Region (2 APO cycles)<br />

WP8 APO cycles in France (1 APO cycle)<br />

WP9 APO cycles in Hispano-America (6 APO cycles)<br />

WP10 Analysis of the audit results<br />

WP11 Evaluation and working conference<br />

WP12 Preparing material for media campaigns<br />

M1 Guidelines for professionals completed Month 6<br />

M2 Initial registration completed Month 13<br />

M3 Intervention completed Month 21<br />

M4 Working conference completed Month 35<br />

Total project period: 3 years (2007-2009)<br />

Month<br />

6 12 18 24 30 36<br />

M1 M2 M3 M4


Financing<br />

EU-contribution:<br />

Own financing 1 :<br />

Total project cost:<br />

1,5 million €<br />

0,8 million €<br />

2,3 million €<br />

1 By contribution of permanent staff of the<br />

participants

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!